In Vitro and in Vivo Immunomodulatory Effects of Triptolide Administered in Acute Kidney Allograft Rejection

蔡龙俊,张古田,吴鸿雁,刘勇,陈军浩,付阳,郭宏骞,周乙华,孙则禹
DOI: https://doi.org/10.3760/cma.j.issn.0254-1785.2014.03.011
2014-01-01
Abstract:Objective Triptolide (TPT),a component of the Chinese herb Triptergium wilfordii,has potent immunosuppressive and anti-inflammatory activity and is clinically used in recipients of kidney transplantation.This work aimed to investigate the effect of TPT on the differentiation of regulatory lymphocytes (Tregs) from CD4+ cells in rats and on preventing rejection in vivo.Method MACS-purified rat CD4+ cells were costimulated with anti-CD3 and anti-CD28 in the presence of TGF-beta1 to induce the expression of Forkhead box P3 (FoxP3) that was detected by ? ow cytometry.TPT and cyclosporine A (CsA) were separately added into the cultures to observe the effect on the expression of FoxP3.Kidney transplantation was performed on rats that either received no treatment or were treated with TPT after transplantation.Result TPT treatment enhanced the expression of Foxp3 in CD4+ cells,whereas CsA inhibited the Foxp3 expression.In the rat kidney transplantation model,the recipient rats treated with TPT survived longer than the control rats (18 vs.7 days,P<0.05).Meanwhile,the percentates of FoxP3+ T cells in the spleens of TPT treated rats were higher than those from the untreated rats (12.4% vs.4.7%,P<0.05).It was also found graft-infiltrating T cells were significantly decreased in TPT-treated recipients.Conclusion These data suggest that TPT may promote the differentiation of CD4+ cells to Foxp3 + Treg cells,which would be at least one of the mechanisms responsible for the immunosuppressive activity of TPT.
What problem does this paper attempt to address?